Lower buprenorphine elimination rate constant is associated with lower opioid use
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-2072
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Lower buprenorphine elimination rate constant is associated with lower opioid use ; volume:239 ; number:10 ; day:12 ; month:8 ; year:2022 ; pages:3213-3221 ; date:10.2022
Psychopharmacology ; 239, Heft 10 (12.8.2022), 3213-3221, 10.2022
- Urheber
-
Elarabi, Hesham Farouk
Lee, Amanda J.
Adem, Abdu
Elrasheed, Abuelgasim
Marsden, John
Ghaferi, Hamad Al
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00213-022-06202-9
- URN
-
urn:nbn:de:101:1-2022120309094002544949
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Elarabi, Hesham Farouk
- Lee, Amanda J.
- Adem, Abdu
- Elrasheed, Abuelgasim
- Marsden, John
- Ghaferi, Hamad Al
- SpringerLink (Online service)
Ähnliche Objekte (12)
Single high-dose buprenorphine for opioid craving during withdrawal
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Buprenorphine - the unique opioid analgesic : pharmacology and clinical application ; 13 tables
Buprenorphine – The ideal drug for most clinical indications for an opioid?
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Lower Manhattan
Lower Manhattan
Lower Canada
Lower California.
Single high-dose buprenorphine for opioid craving during withdrawal
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Buprenorphine - the unique opioid analgesic : pharmacology and clinical application ; 13 tables
Buprenorphine – The ideal drug for most clinical indications for an opioid?
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Lower Manhattan
Lower Manhattan
Lower Canada
Lower California.
Single high-dose buprenorphine for opioid craving during withdrawal
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Buprenorphine - the unique opioid analgesic : pharmacology and clinical application ; 13 tables
Buprenorphine – The ideal drug for most clinical indications for an opioid?
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Lower Manhattan
Lower Manhattan
Lower Canada